OMERS ADMINISTRATION Corp Has $7.10 Million Stock Holdings in HCA Healthcare, Inc. $HCA

OMERS ADMINISTRATION Corp lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 17.8% during the first quarter, HoldingsChannel reports. The firm owned 14,997 shares of the company’s stock after acquiring an additional 2,263 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in HCA Healthcare were worth $7,097,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $31,000. Cedar Mountain Advisors LLC acquired a new position in HCA Healthcare during the first quarter worth approximately $33,000. MCF Advisors LLC lifted its position in shares of HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after buying an additional 49 shares during the last quarter. Finally, Basepoint Wealth LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $35,000. 62.73% of the stock is owned by institutional investors.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

Wall Street Analysts Forecast Growth

A number of research firms have commented on HCA. JPMorgan Chase & Co. reduced their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Argus lowered their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. TD Cowen decreased their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Finally, KeyCorp dropped their target price on HCA Healthcare from $510.00 to $475.00 and set an “overweight” rating for the company in a report on Tuesday, July 14th. Fourteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $483.45.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $382.28 on Monday. The stock has a market capitalization of $84.80 billion, a PE ratio of 12.80, a P/E/G ratio of 1.29 and a beta of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The business has a fifty day moving average price of $386.95 and a two-hundred day moving average price of $453.56.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the business earned $6.84 earnings per share. On average, equities analysts expect that HCA Healthcare, Inc. will post 29.19 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.